Effects of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Total Knee Replacement (TKA).

Trial Profile

Effects of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Total Knee Replacement (TKA).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2012

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2012 Primary endpoints amended as reported by ClinicalTrials.gov.
    • 16 Apr 2012 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
    • 16 Apr 2012 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top